# US 2002/0165277 A1 · Virucidal compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0165277 A1
- Document ID: US20020165277A1
- Status: Published application
- Kind: A1
- Application number: 09/795,279
- Filed: 2001-02-28
- Published: 2002-11-07
- Earliest claimed: 2001-02-28
- Inventors: Thomas W. Konowalchuk; Jack Konowalchuk
- Web page: https://patentgrep.com/patent/US20020165277A1

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/22: for herpes viruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of inactivating enveloped virus comprises contacting said virus with a virucidally effective amount of a composition comprising a C1 to C3 monohydroxy alcohol or a C3 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated with herpes infections. Pharmaceutical compositions for use in the present method are provided.

## Claims

### Claim 1

A composition for inactivating an enveloped virus, consisting essentially of a C1-C3 alcohol or a C2-C4 diol and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said alcohol is selected from the group consisting of methanol, ethanol, 1-propanol, and 2-propanol.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said alcohol is selected from the group consisting of 2,3-butanediol, 1,2-butanediol, 1,3-butanediol, and 1,4-butanediol.

### Claim 4 (depends on 2)

The composition of claim 2, wherein said alcohol is ethanol.

### Claim 5 (depends on 1)

The composition of claim 1, wherein said acid is an organic acid.

### Claim 6 (depends on 5)

The composition of claim 5, wherein said organic acid selected from the group consisting of glycolic acid, lactic acid, succinic acid, malic acid, citric acid and acetic acid.

### Claim 7 (depends on 1)

The composition of claim 1, wherein said acid is an inorganic acid.

### Claim 8 (depends on 7)

The composition of claim 7, wherein said acid is hydrochloric acid.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the pH of said composition is 2.45.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the concentration of said alcohol in said composition is between about 0.2% and 12.5% by volume.

### Claim 11 (depends on 1)

The composition of claim 1, wherein said virus is a member of the Herpesviridae family.

### Claim 12 (depends on 11)

The composition of claim 11, wherein said virus is herpes simplex 1.

### Claim 13 (depends on 11)

The composition of claim 11, wherein said virus is herpes simplex 2.

### Claim 14 (depends on 11)

The composition of claim 11, wherein said virus is Varicella-zoster virus.

### Claim 15 (depends on 11)

The composition of claim 11, wherein said composition is applied topically to reduce or inhibit lesions in an animal or human suffering from an infection by said virus.

### Claim 16 (depends on 1)

The composition of claim 1, wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.

### Claim 17

An aqueous composition for treating an inflammation or lesion caused by herpesvirus consisting essentially of 10% by volume ethanol and 0.6% by weight glycolic acid.

### Claim 18 (depends on 17)

The composition of claim 17, wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.

### Claim 19

An aqueous composition for preventing a lesion caused by herpesvirus consisting essentially of 10% by volume ethanol and 0.6% by weight glycolic acid.

### Claim 20 (depends on 19)

The composition of claim 19, wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.

### Claim 21

A method of inactivating an enveloped virus, comprising contacting said virus with a virucidally effective amount of a composition consisting essentially of a C1-C3 alcohol or a C2-C4 diol and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less.

### Claim 22 (depends on 21)

The method of claim 21, wherein said alcohol is selected from the group consisting of methanol, ethanol, 1-propanol, and 2-propanol.

### Claim 23 (depends on 21)

The method of claim 21, wherein said alcohol is selected from the group consisting of 2,3-butanediol, 1,2-butanediol, 1,3-butanediol, and 1,4-butanediol.

### Claim 24 (depends on 22)

The method of claim 22, wherein said alcohol is ethanol.

### Claim 25 (depends on 21)

The method of claim 21, wherein said acid is an organic acid.

### Claim 26 (depends on 25)

The method of claim 25, wherein said organic acid selected from the group consisting of glycolic acid, lactic acid, succinic acid, malic acid, citric acid and acetic acid.

### Claim 27 (depends on 21)

The method of claim 21, wherein said acid is an inorganic acid.

### Claim 28 (depends on 27)

The method of claim 27, wherein said acid is hydrochloric acid.

### Claim 29 (depends on 21)

The method of claim 21, wherein the pH of said composition is 2.45.

### Claim 30 (depends on 21)

The method of claim 21, wherein the concentration of said alcohol in said composition is between about 0.2% and 12.5% by volume.

### Claim 31 (depends on 21)

The method of claim 21, wherein said virus is a member of the Herpesviridae family.

### Claim 32 (depends on 31)

The method of claim 31, wherein said virus is herpes simplex 1.

### Claim 33 (depends on 31)

The method of claim 31, wherein said virus is herpes simplex 2.

### Claim 34 (depends on 31)

The method of claim 31, wherein said virus is Varicella-zoster virus.

### Claim 35 (depends on 31)

The method of claim 31, wherein said composition is applied topically to reduce or inhibit lesions in an animal or human suffering from an infection by said virus.

### Claim 36 (depends on 21)

The method of claim 21, wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.

### Claim 37

A method for treating an inflammation or lesion caused by herpesvirus, comprising topically applying to said inflammation or lesion a composition consisting essentially of 10% by volume ethanol and 0.6% by weight glycolic acid.

### Claim 38 (depends on 37)

The method of claim 37, wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.

### Claim 39

A method for preventing lesions caused by herpesvirus, comprising topically applying a composition consisting essentially of 10% by volume ethanol and 0.6% by weight glycolic acid, wherein said composition is applied during symptoms of pain, itching, burning, or tingling.

### Claim 40 (depends on 39)

The method of claim 39, wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.
